Literature DB >> 34649835

Exploiting cancer's drinking problem: regulation and therapeutic potential of macropinocytosis.

Joseph Puccini1, Michael Alexander Badgley1, Dafna Bar-Sagi2.   

Abstract

Macropinocytosis, an evolutionarily conserved endocytic mechanism that mediates non-specific fluid-phase uptake, is potently upregulated by various oncogenic pathways. It is now well appreciated that high macropinocytic activity is a hallmark of many human tumors, which use this adaptation to scavenge extracellular nutrients for fueling cell growth. In the context of the nutrient-scarce tumor microenvironment, this process provides tumor cells with metabolic flexibility. However, dependence on this scavenging mechanism also illuminates a potential metabolic vulnerability. As such, there is a great deal of interest in understanding the molecular underpinnings of macropinocytosis. In this review, we will discuss the most recent advances in characterizing macropinocytosis: the pathways that regulate it, its contribution to the metabolic fitness of cancer cells, and its therapeutic potential.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  RAS; macropinocytosis; membrane ruffling; metabolic fitness; nutrient scavenging

Mesh:

Year:  2021        PMID: 34649835      PMCID: PMC8702483          DOI: 10.1016/j.trecan.2021.09.004

Source DB:  PubMed          Journal:  Trends Cancer        ISSN: 2405-8025


  85 in total

1.  PTEN Deficiency and AMPK Activation Promote Nutrient Scavenging and Anabolism in Prostate Cancer Cells.

Authors:  Seong M Kim; Tricia T Nguyen; Archna Ravi; Peter Kubiniok; Brendan T Finicle; Vaishali Jayashankar; Leonel Malacrida; Jue Hou; Jane Robertson; Dong Gao; Jonathan Chernoff; Michelle A Digman; Eric O Potma; Bruce J Tromberg; Pierre Thibault; Aimee L Edinger
Journal:  Cancer Discov       Date:  2018-03-23       Impact factor: 39.397

2.  Combined mTORC1/mTORC2 inhibition blocks growth and induces catastrophic macropinocytosis in cancer cells.

Authors:  Ritesh K Srivastava; Changzhao Li; Jasim Khan; Nilam Sanjib Banerjee; Louise T Chow; Mohammad Athar
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-15       Impact factor: 11.205

3.  Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumors.

Authors:  Shawn M Davidson; Oliver Jonas; Mark A Keibler; Han Wei Hou; Alba Luengo; Jared R Mayers; Jeffrey Wyckoff; Amanda M Del Rosario; Matthew Whitman; Christopher R Chin; Kendall J Condon; Alex Lammers; Katherine A Kellersberger; Brian K Stall; Gregory Stephanopoulos; Dafna Bar-Sagi; Jongyoon Han; Joshua D Rabinowitz; Michael J Cima; Robert Langer; Matthew G Vander Heiden
Journal:  Nat Med       Date:  2016-12-26       Impact factor: 53.440

Review 4.  Shaping cups into phagosomes and macropinosomes.

Authors:  Joel A Swanson
Journal:  Nat Rev Mol Cell Biol       Date:  2008-07-09       Impact factor: 94.444

5.  Macropinocytosis as a Key Determinant of Peptidomimetic Uptake in Cancer Cells.

Authors:  Daniel Y Yoo; Stephanie A Barros; Gordon C Brown; Christian Rabot; Dafna Bar-Sagi; Paramjit S Arora
Journal:  J Am Chem Soc       Date:  2020-08-13       Impact factor: 15.419

6.  Therapeutically reprogrammed nutrient signalling enhances nanoparticulate albumin bound drug uptake and efficacy in KRAS-mutant cancer.

Authors:  Ran Li; Thomas S C Ng; Stephanie J Wang; Mark Prytyskach; Christopher B Rodell; Hannes Mikula; Rainer H Kohler; Michelle A Garlin; Douglas A Lauffenburger; Sareh Parangi; Daniela M Dinulescu; Nabeel Bardeesy; Ralph Weissleder; Miles A Miller
Journal:  Nat Nanotechnol       Date:  2021-05-06       Impact factor: 40.523

7.  Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions.

Authors:  Orianne Olivares; Jared R Mayers; Victoire Gouirand; Margaret E Torrence; Tristan Gicquel; Laurence Borge; Sophie Lac; Julie Roques; Marie-Noëlle Lavaut; Patrice Berthezène; Marion Rubis; Veronique Secq; Stéphane Garcia; Vincent Moutardier; Dominique Lombardo; Juan Lucio Iovanna; Richard Tomasini; Fabienne Guillaumond; Matthew G Vander Heiden; Sophie Vasseur
Journal:  Nat Commun       Date:  2017-07-07       Impact factor: 14.919

8.  Loss of expression of the recycling receptor, FcRn, promotes tumor cell growth by increasing albumin consumption.

Authors:  Rafal Swiercz; Min Mo; Priyanka Khare; Zita Schneider; Raimund J Ober; Elizabeth Sally Ward
Journal:  Oncotarget       Date:  2017-01-10

9.  Intracellular nanoparticle delivery by oncogenic KRAS-mediated macropinocytosis.

Authors:  Xinquan Liu; Debadyuti Ghosh
Journal:  Int J Nanomedicine       Date:  2019-08-16

10.  Plasma membrane V-ATPase controls oncogenic RAS-induced macropinocytosis.

Authors:  Craig Ramirez; Andrew D Hauser; Emily A Vucic; Dafna Bar-Sagi
Journal:  Nature       Date:  2019-12-11       Impact factor: 49.962

View more
  4 in total

Review 1.  Unconventional Functions of Amino Acid Transporters: Role in Macropinocytosis (SLC38A5/SLC38A3) and Diet-Induced Obesity/Metabolic Syndrome (SLC6A19/SLC6A14/SLC6A6).

Authors:  Yangzom D Bhutia; Marilyn Mathew; Sathish Sivaprakasam; Sabarish Ramachandran; Vadivel Ganapathy
Journal:  Biomolecules       Date:  2022-01-31

2.  Macropinocytosis is an alternative pathway of cysteine acquisition and mitigates sorafenib-induced ferroptosis in hepatocellular carcinoma.

Authors:  Jun-Kyu Byun; Seunghyeong Lee; Gil Won Kang; Yu Rim Lee; Soo Young Park; Im-Sook Song; Jae Won Yun; Jaebon Lee; Yeon-Kyung Choi; Keun-Gyu Park
Journal:  J Exp Clin Cancer Res       Date:  2022-03-14

3.  GRP75-driven, cell-cycle-dependent macropinocytosis of Tat/pDNA-Ca2+ nanoparticles underlies distinct gene therapy effect in ovarian cancer.

Authors:  Linjia Su; Zhe Sun; Fangzheng Qi; Huishan Su; Luomeng Qian; Jing Li; Liang Zuo; Jinhai Huang; Zhilin Yu; Jinping Li; Zhinan Chen; Sihe Zhang
Journal:  J Nanobiotechnology       Date:  2022-07-20       Impact factor: 9.429

Review 4.  The Role and Therapeutic Potential of Macropinocytosis in Cancer.

Authors:  Zejing Qiu; Wencheng Liu; Qianru Zhu; Kun Ke; Qicong Zhu; Weiwei Jin; Shuxian Yu; Zuyi Yang; Lin Li; Xiaochen Sun; Shuyi Ren; Yanfen Liu; Zhiyu Zhu; Jiangping Zeng; Xiaoyu Huang; Yan Huang; Lu Wei; Mengmeng Ma; Jun Lu; Xiaoyang Chen; Yiping Mou; Tian Xie; Xinbing Sui
Journal:  Front Pharmacol       Date:  2022-08-15       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.